Dedicated to serving significant unmet medical needs, GenFleet Therapeutics constructs its R&D platform on the basis of disease biology and translational medicine, and researches into latest biological mechanism of cancer pathways, tumor microenvironment and human immunoregulation. GenFleet's rich and diversified pipeline highlights multiple cutting-edge products with novel mechanisms and global intellectual property rights. Through years of endeavor, GenFleet has set up industry-leading capabilities and expertise in developing novel drugs - both small molecules and biologics. Its cutting-edge pipeline includes over 10 products, three of which have progressed into clinical stages. As more projects move into late-stage clinical trials, GenFleet is expected to unravel its blueprint of commercialization during the next 3-5 years.
View Top Employees from GenFleet TherapeuticsWebsite | http://www.genfleet.com/en |
Revenue | $3 million |
Funding | $50 million |
Employees | 25 (11 on RocketReach) |
Founded | 2017 |
Address | 1206 Zhangjiang Rd Bldg A, Shanghai, Shanghai, CN |
Phone | +86 21 6882 1388 |
Industry | Pharmaceutical Manufacturing, Drug Manufacturing & Research, Biotechnology, Pharmaceuticals, Science and Engineering, Healthcare, Health Care |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 54 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular GenFleet Therapeutics employee's phone or email?
The GenFleet Therapeutics annual revenue was $3 million in 2024.
Qiang LU is the Chairman and Founder of GenFleet Therapeutics.
11 people are employed at GenFleet Therapeutics.
GenFleet Therapeutics is based in Shanghai, Shanghai.
The NAICS codes for GenFleet Therapeutics are [541, 32541, 3254, 54, 325, 32].
The SIC codes for GenFleet Therapeutics are [87, 873].